These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 32119892)

  • 1. Bullous pemphigoid: Rituximab to the rescue?
    Heymann WR
    J Am Acad Dermatol; 2020 May; 82(5):1089-1090. PubMed ID: 32119892
    [No Abstract]   [Full Text] [Related]  

  • 2. Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series.
    Abdat R; Waldman RA; de Bedout V; Czernik A; Mcleod M; King B; Gordon S; Ahmed R; Nichols A; Rothe M; Rosmarin D
    J Am Acad Dermatol; 2020 Jul; 83(1):46-52. PubMed ID: 32179082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab in autoimmune pemphigoid diseases: Indications, optimized regimens, and practice gaps.
    Thomas RM; Colon A; Motaparthi K
    Clin Dermatol; 2020; 38(3):384-396. PubMed ID: 32563354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment.
    Di Lernia V; Casanova DM; Goldust M; Ricci C
    Dermatol Pract Concept; 2020 Jul; 10(3):e2020050. PubMed ID: 32642305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Future of Bullous Pemphigoid (BP): New and Promising Drugs May Revolutionize Treatment Course for BP Patients.
    Ben-Shoshan D; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(2):191-192. PubMed ID: 32208024
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of T cells in pemphigus vulgaris and bullous pemphigoid.
    Fang H; Li Q; Wang G
    Autoimmun Rev; 2020 Nov; 19(11):102661. PubMed ID: 32942041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Bullous Pemphigoid in People Aged 80 Years and Older: A Systematic Review of the Literature.
    Oren-Shabtai M; Kremer N; Lapidoth M; Sharon E; Atzmony L; Nosrati A; Hodak E; Mimouni D; Levi A
    Drugs Aging; 2021 Feb; 38(2):125-136. PubMed ID: 33230804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune bullous skin diseases, pemphigus and pemphigoid.
    Egami S; Yamagami J; Amagai M
    J Allergy Clin Immunol; 2020 Apr; 145(4):1031-1047. PubMed ID: 32272980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita.
    Patel PM; Jones VA; Murray TN; Amber KT
    Am J Clin Dermatol; 2020 Aug; 21(4):557-565. PubMed ID: 32180161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Understanding Pemphigus and Bullous Pemphigoid.
    Hammers CM; Stanley JR
    J Invest Dermatol; 2020 Apr; 140(4):733-741. PubMed ID: 32200875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous Pemphigoid: Trigger and Predisposing Factors.
    Moro F; Fania L; Sinagra JLM; Salemme A; Di Zenzo G
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 4 and interleukin 13 inhibition: A promising therapeutic approach in bullous pemphigoid.
    Geller S
    J Am Acad Dermatol; 2020 Jul; 83(1):37-38. PubMed ID: 32179081
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.
    Beyzaee AM; Rahmatpour Rokni G; Patil A; Goldust M
    Dermatol Ther; 2021 Jan; 34(1):e14405. PubMed ID: 33051960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic improvement of bullous pemphigoid with omalizumab in an elderly patient.
    Navarro-Triviño FJ; Llamas-Molina JM; Ayen-Rodriguez A; Cancela-Díez B; Ruiz-Villaverde R
    Eur J Hosp Pharm; 2021 Nov; 28(6):350-352. PubMed ID: 32920533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing evidence for omalizumab in the treatment of bullous pemphigoid.
    Lonowski S; Sachsman S; Patel N; Truong A; Holland V
    JAAD Case Rep; 2020 Mar; 6(3):228-233. PubMed ID: 32140524
    [No Abstract]   [Full Text] [Related]  

  • 16. A Systematic Review of Drug-Induced Pemphigoid.
    Verheyden MJ; Bilgic A; Murrell DF
    Acta Derm Venereol; 2020 Aug; 100(15):adv00224. PubMed ID: 32176310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous pemphigoid.
    Korman N
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):907-24. PubMed ID: 3294944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid.
    Zhang Y; Xu Q; Chen L; Chen J; Zhang J; Zou Y; Gong T; Ji C
    Front Immunol; 2021; 12():738907. PubMed ID: 34721404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid.
    Zhou T; Peng B; Geng S
    Front Immunol; 2021; 12():718073. PubMed ID: 34504496
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.